Abstract:Complex structural chromosome abnormalities such as chromoanagenesis have been reported in acute myeloid leukemia (AML). They are usually not well characterized by conventional genetic methods, and the characterization of chromoanagenesis structural abnormalities from short-read sequencing still presents challenges. Here, we characterized complex structural abnormalities involving chromosomes 2, 3, and 7 in an AML patient using an integrated approach including CRISPR/Cas9-mediated nanopore sequencing, mate pair sequencing (MPseq), and SNP microarray analysis along with cytogenetic methods. SNP microarray analysis revealed chromoanagenesis involving chromosomes 3 and 7, and a pseudotricentric chromosome 7 was revealed by cytogenetic methods. MPseq revealed 138 structural variants (SVs) as putative junctions of complex rearrangements involving chromosomes 2, 3, and 7, which led to 16 novel gene fusions and 33 truncated genes. Thirty CRISPR RNA (crRNA) sequences were designed to map 29 SVs, of which 27 (93.1%) were on-target based on CRISPR/Cas9 crRNA nanopore sequencing. In addition to simple SVs, complex SVs involving over two breakpoints were also revealed. Twenty-one SVs (77.8% of the on-target SVs) were also revealed by MPseq with shared SV breakpoints. Approximately three-quarters of breakpoints were located within genes, especially intronic regions, and one-quarter of breakpoints were intergenic. Alu and LINE repeat elements were frequent among breakpoints. Amplification of the chromosome 7 centromere was also detected by nanopore sequencing. Given the high amplification of the chromosome 7 centromere, extra chromosome 7 centromere sequences (tricentric), and more gains than losses of genomic material, chromoanasynthesis and chromothripsis may be responsible for forming this highly complex structural abnormality. We showed this combination approach's value in characterizing complex structural abnormalities for clinical and research applications. Characterization of these complex structural chromosome abnormalities not only will help understand the molecular mechanisms responsible for the process of chromoanagenesis, but also may identify specific molecular targets and their impact on therapy and overall survival.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: in acute myeloid leukemia (AML), complex chromosomal structural abnormalities (such as chromosomal rearrangements) are difficult to be fully characterized by traditional genetic methods. In particular, short - read - length sequencing techniques still face challenges in analyzing these complex structural abnormalities. For this reason, the researchers adopted an integrated approach, including CRISPR/Cas9 - mediated nanopore sequencing, mate - pair sequencing (MPseq), and cytogenetic methods, to characterize in detail the complex structural rearrangements involving chromosomes 2, 3, and 7. Specifically, the paper aims to: 1. **Analyze complex chromosomal structural abnormalities**: Use a variety of advanced sequencing techniques and cytogenetic methods to comprehensively analyze the complex structural rearrangements involving chromosomes 2, 3, and 7 in AML patients. 2. **Reveal new gene fusions and truncated genes**: 138 structural variants (SVs) were discovered through MPseq, of which 16 were new gene fusion events and 33 were truncated genes. 3. **Verify the accuracy of CRISPR/Cas9 - mediated nanopore sequencing**: 30 CRISPR RNA (crRNA) sequences were designed to target 29 SVs, and the results showed that 93.1% of the crRNA could accurately target the target regions. 4. **Explore the formation mechanisms of complex structural abnormalities**: Combining high - resolution sequencing data, the researchers found the amplification of the centromere of chromosome 7 and the existence of tricentric chromosomes, and speculated that chromoanasynthesis and chromothripsis might be the causes of these complex structural abnormalities. Through this method, the research not only helps to understand the molecular mechanisms of chromosomal rearrangements, but also may identify specific molecular targets and their impacts on treatment and overall survival. ### Formula Examples To ensure the correctness and readability of formulas, the following are the Markdown - format presentations of some formulas and concepts involved in the paper: - **CRISPR/Cas9 System**: CRISPR/Cas9 is an RNA - guided DNA endonuclease system that can specifically cut the target DNA sequence. Its mechanism of action can be represented by the following formulas: \[ \text{Cas9}+\text{sgRNA}\to\text{Cas9 - sgRNA complex} \] \[ \text{Cas9 - sgRNA complex}+\text{target DNA}\to\text{double - strand break (DSB)} \] - **Structural Variation (SVs) Detection**: Structural variations can be detected by a combination of multiple algorithms, such as read - pair, split - read, and read - depth/count methods. The formula is as follows: \[ \text{SV detection}=\text{read - pair}+\text{split - read}+\text{read - depth/count} \] - **Gene Fusion and Truncated Genes**: The formation of gene fusions and truncated genes can be represented by the following formulas: \[ \text{gene A}+\text{gene B}\to\text{gene fusion} \] \[ \text{gene X}\to\text{truncated gene Y} \] These formulas help readers better understand the techniques and mechanisms mentioned in the paper.

An Integrated Approach Including CRISPR/Cas9-Mediated Nanopore Sequencing, Mate Pair Sequencing, and Cytogenomic Methods to Characterize Complex Structural Rearrangements in Acute Myeloid Leukemia